Sagimet Biosciences Inc. (SGMT)
Nasdaq: SGMT · Pharmaceutical Preparations · San Mateo, CA · filing with the SEC since 2007
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 |
| Report filed | Mar 11, 2026 | Mar 12, 2025 | Mar 25, 2024 | · |
| Revenue | · | · | 2,000 | · |
| Research and development | 39,054 | 38,444 | 19,777 | 24,919 |
| General and administrative | 17,835 | 16,010 | 12,963 | 6,136 |
| Total operating expenses | 56,889 | 54,454 | 32,740 | 31,055 |
| Operating income | -56,889 | -54,454 | -30,740 | -31,055 |
| Other income (expense), net | 5,851 | 8,887 | 2,864 | 556 |
| Income tax expense | 0 | 0 | · | · |
| Net income | -51,038 | -45,567 | -27,876 | -30,499 |
| Earnings per share, basic | -1.58 | -1.45 | -2.66 | -165.20 |
| Earnings per share, diluted | -1.58 | -1.45 | -2.66 | -165.20 |
| Weighted average shares, basic | 32,345,525 | 31,350,725 | 10,460,335 | 184,619 |
| Weighted average shares, diluted | 32,345,525 | 31,350,725 | 10,460,335 | 184,619 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
us-gaap:GeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossOther income (expense), net gains and costs outside the business
us-gaap:OtherNonoperatingIncomeExpenseIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding